This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Aug;34(6):611-4.

doi: 10.1007/s10875-014-0057-9. Epub 2014 Jun 3.

SCIg vs. IVIg: let's give patients the choice!

K Samaan¹, M C Levasseur, H Decaluwe, C St-Cyr, H Chapdelaine, A Des Roches, E Haddad

Affiliations

Affiliation

¹ Department of Pediatrics, University of Montreal, Centre Hospitalier Universitaire Sainte-Justine, 3175 Chemin de la Cote-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada.

PMID: 24888599
DOI: 10.1007/s10875-014-0057-9

SCIg vs. IVIg: let's give patients the choice!

K Samaan et al. J Clin Immunol. 2014 Aug.

. 2014 Aug;34(6):611-4.

doi: 10.1007/s10875-014-0057-9. Epub 2014 Jun 3.

Authors

K Samaan¹, M C Levasseur, H Decaluwe, C St-Cyr, H Chapdelaine, A Des Roches, E Haddad

Affiliation

¹ Department of Pediatrics, University of Montreal, Centre Hospitalier Universitaire Sainte-Justine, 3175 Chemin de la Cote-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada.

PMID: 24888599
DOI: 10.1007/s10875-014-0057-9

No abstract available

PubMed Disclaimer

Similar articles

Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: a multicenter study in Argentina.
Bezrodnik L, Gómez Raccio A, Belardinelli G, Regairaz L, Díaz Ballve D, Seminario G, Moreira I, Riganti C, Cantisano C, Díaz H, Di Giovanni D. Bezrodnik L, et al. J Clin Immunol. 2013 Oct;33(7):1216-22. doi: 10.1007/s10875-013-9916-z. Epub 2013 Jul 12. J Clin Immunol. 2013. PMID: 23846854
Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
Perraudin C, Bourdin A, Spertini F, Berger J, Bugnon O. Perraudin C, et al. J Clin Immunol. 2016 Jul;36(5):502-10. doi: 10.1007/s10875-016-0288-z. Epub 2016 May 2. J Clin Immunol. 2016. PMID: 27139500
Intravenous and subcutaneous immunoglobulin replacement: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies.
Soler-Palacín P, Gasó-Gago I, Fernández-Polo A, Martín-Nalda A, Oliveras M, Martinez-Cutillas J, Figueras C. Soler-Palacín P, et al. J Clin Immunol. 2014 Nov;34(8):1015-7. doi: 10.1007/s10875-014-0096-2. Epub 2014 Sep 5. J Clin Immunol. 2014. PMID: 25190197
Why I use subcutaneous immunoglobulin (SCIG).
Shapiro RS. Shapiro RS. J Clin Immunol. 2013 Jan;33 Suppl 2:S95-8. doi: 10.1007/s10875-012-9853-2. Epub 2012 Dec 21. J Clin Immunol. 2013. PMID: 23264027 Review.
Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease.
Bonagura VR. Bonagura VR. J Clin Immunol. 2013 Jan;33 Suppl 2:S90-4. doi: 10.1007/s10875-012-9838-1. Epub 2012 Dec 28. J Clin Immunol. 2013. PMID: 23271459 Review.

See all similar articles

Cited by

Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.
Sultan S, Rondeau É, Levasseur MC, Dicaire R, Decaluwe H, Haddad É. Sultan S, et al. J Clin Immunol. 2017 Jul;37(5):496-504. doi: 10.1007/s10875-017-0409-3. Epub 2017 Jun 8. J Clin Immunol. 2017. PMID: 28597145
Home-Based Treatment with Immunoglobulins: an Evaluation from the Perspective of Patients and Healthcare Professionals.
Zuizewind CA, van Kessel P, Kramer CM, Muijs MM, Zwiers JC, Triemstra M. Zuizewind CA, et al. J Clin Immunol. 2018 Nov;38(8):876-885. doi: 10.1007/s10875-018-0566-z. Epub 2018 Nov 12. J Clin Immunol. 2018. PMID: 30421274 Free PMC article.
Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review.
Overton PM, Shalet N, Somers F, Allen JA. Overton PM, et al. Patient Prefer Adherence. 2021 Apr 19;15:811-834. doi: 10.2147/PPA.S303279. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33907384 Free PMC article. Review.
Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS).
Vultaggio A, Azzari C, Ricci S, Martire B, Palladino V, Gallo V, Pecoraro A, Pignata C, Spadaro G, Graziani S, Moschese V, Trizzino A, Boggia GM, Matucci A. Vultaggio A, et al. J Clin Immunol. 2018 Jul;38(5):602-609. doi: 10.1007/s10875-018-0528-5. Epub 2018 Jun 28. J Clin Immunol. 2018. PMID: 29951948 Free PMC article.
Shared decision making: Does a physician's decision-making style affect patient participation in treatment choices for primary immunodeficiency?
Lamb CC, Wang Y, Lyytinen K. Lamb CC, et al. J Eval Clin Pract. 2019 Dec;25(6):1102-1110. doi: 10.1111/jep.13162. Epub 2019 May 22. J Eval Clin Pract. 2019. PMID: 31115958 Free PMC article.

See all "Cited by" articles

References

1. J Allergy Clin Immunol. 2006 Apr;117(4 Suppl):S525-53 - PubMed
1. Clin Rev Allergy Immunol. 2005 Dec;29(3):173-84 - PubMed
1. J Allergy Clin Immunol. 2004 Oct;114(4):936-42 - PubMed
1. J Clin Immunol. 2012 Dec;32(6):1153-64 - PubMed
1. J Allergy Clin Immunol. 2008 Nov;122(5):1038-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information